Shopping Cart 0
Cart Subtotal
USD 0

Sawai Pharmaceutical Co Ltd (4555) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Sawai Pharmaceutical Co Ltd (Sawai Pharmaceutical) manufactures, sells, imports and exports ethical drugs and proprietary drugs. The company's products include cardiovascular drugs, antihyperlipidemic agents, diabetes drugs, anticancer drugs, and OTC drugs. It provides products in the form of tablets, oral dispersing tablets, capsules, granule, injection, tape, ophthalmic and nasal solution, and syrup. Sawai Pharmaceutical caters to hospitals, general practitioners and dispensing pharmacies. The company has manufacturing facilities in Kanto, Osaka, Sanda and Kyusyu. It has its presence in Sapporo, Sendai, Kitakanto, Tokyo Daiichi, Tokyo Daini, Nagoya, Osaka, Hiroshima and Fukuoka. Sawai Pharmaceutical is headquartered in Osaka, Japan.

Sawai Pharmaceutical Co Ltd (4555)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 12

Asset Purchase 12

Upsher-Smith Labs Acquires 20 US Generic Products from Sandoz 12

Sawai Pharma to Acquire Kashima Plant from Mitsubishi Tanabe Pharma Factory for USD39.3 Million 13

Partnerships 14

Upsher-Smith Enters into Marketing and Distribution Agreement 14

Sawai Pharmaceutical Enters Into Manufacturing And Marketing Agreement with AstraZeneca 15

Upsher-Smith Labs Enters into Agreement 16

Upsher-Smith Labs Enters into Agreement with Bluepharma Industria Farmaceutica 17

Upsher-Smith Labs Enters into Agreement with Pharmathen 18

Upsher-Smith Laboratories Enters into Agreement with pharmaceutical company 19

Upsher-Smith Labs Enters Into Development Agreement With Lundbeck 20

Equity Offering 21

Sawai Pharma to Raise USD37.7 Million in Private Placement of Shares 21

Asset Transactions 22

Vertical Pharma Acquires Portfolio Of Womens Health Products From Upsher-Smith Labs 22

Acquisition 24

Sawai Pharma Sells 20% stake in Upsher-Smith Lab for USD211 Million 24

Sumitomo Corporation of America to Acquire 20% Stake in Sawai America for USD211 Million 25

Sawai Pharma Acquires Generic Pharmaceuticals Business of Upsher-Smith Labs from Acova for USD1.05 Billion 26

Upsher-Smith Completes Acquisition Of Remaining 84% Stake In Proximagen For Up To USD 555 Million 28

Sawai Pharmaceutical Co Ltd-Key Competitors 30

Sawai Pharmaceutical Co Ltd-Key Employees 31

Sawai Pharmaceutical Co Ltd-Locations And Subsidiaries 32

Head Office 32

Other Locations & Subsidiaries 32

Recent Developments 33

Corporate Communications 33

May 15, 2018: Sawai Pharmaceutical Announce Personnel Changes 33

Appendix 36

Methodology 36

About GlobalData 36

Contact Us 36

Disclaimer 36


List Of Figure

List of Figures

Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2

Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Sawai Pharmaceutical Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8

Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Upsher-Smith Labs Acquires 20 US Generic Products from Sandoz 12

Sawai Pharma to Acquire Kashima Plant from Mitsubishi Tanabe Pharma Factory for USD39.3 Million 13

Upsher-Smith Enters into Marketing and Distribution Agreement 14

Sawai Pharmaceutical Enters Into Manufacturing And Marketing Agreement with AstraZeneca 15

Upsher-Smith Labs Enters into Agreement 16

Upsher-Smith Labs Enters into Agreement with Bluepharma Industria Farmaceutica 17

Upsher-Smith Labs Enters into Agreement with Pharmathen 18

Upsher-Smith Laboratories Enters into Agreement with pharmaceutical company 19

Upsher-Smith Labs Enters Into Development Agreement With Lundbeck 20

Sawai Pharma to Raise USD37.7 Million in Private Placement of Shares 21

Vertical Pharma Acquires Portfolio Of Womens Health Products From Upsher-Smith Labs 22

Sawai Pharma Sells 20% stake in Upsher-Smith Lab for USD211 Million 24

Sumitomo Corporation of America to Acquire 20% Stake in Sawai America for USD211 Million 25

Sawai Pharma Acquires Generic Pharmaceuticals Business of Upsher-Smith Labs from Acova for USD1.05 Billion 26

Upsher-Smith Completes Acquisition Of Remaining 84% Stake In Proximagen For Up To USD 555 Million 28

Sawai Pharmaceutical Co Ltd, Key Competitors 30

Sawai Pharmaceutical Co Ltd, Key Employees 31

Sawai Pharmaceutical Co Ltd, Subsidiaries 32

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Sawai Pharmaceutical Co Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.